Molina Healthcare Reports Fourth Quarter and Year-End 2016 Results and Provides Fiscal Year 2017 Outlook and Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Jefferies Maintains Hold Rating and $59 PT on Molina Healthcare (MOH) Despite Huge Guidance Miss
February 16, 2017 8:53 AM ESTJefferies analyst David Windley maintains Hold rating and $59 price target on Molina Health (NYSE: MOH), suggesting Medicaid exchange concerns produced a 40%+ guidance miss, while the company reported 2016 fourth quarter EPS figures below estimates.
Windley commented, "We stepped aside in Dec for Medicaid Expansion and Exchange (HIX)... More
Stifel Downgrades Molina Healthcare (MOH) to Hold
February 16, 2017 6:22 AM ESTStifel downgraded Molina Healthcare (NYSE: MOH) from Buy to Hold with a price target of $45.00 (from $64.00).
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $59.89 yesterday.
... MoreMolina Healthcare (MOH) Reports Q4 Loss Per Share of $1.54
February 15, 2017 4:18 PM ESTMolina Healthcare (NYSE: MOH) reported Q4 EPS of ($1.54), may not compare to the analyst estimate of $0.75. Revenue for the quarter came in at $4.46 billion versus the consensus estimate of $4.55 billion.
2017 guidance of $1.72 net income per diluted share and $2.09 adjusted net income... More
